Targeted drug delivery is a significant advantage of nanotechnology in medicine. By functionalizing nanocarriers with specific ligands, such as antibodies or peptides, drugs can be directed to specific cell types, such as cancer cells. This targeted approach ensures a higher concentration of the drug reaches the diseased site, enhancing therapeutic outcomes while minimizing harm to healthy tissues. Consequently, it reduces side effects and improves patient compliance.
